Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc.

Formal notice from Nasdaq on May 26, 2026: Jaguar complies with Bid Price Rule (closing bid ≥$1/sh).
Panel maintains jurisdiction until Sept 1, 2026; Mandatory Panel Monitor imposed until May 26, 2027.
If bid price <$1 for 30 consecutive trading days during monitoring, no 180-day grace period; delisting possible.
CEO Lisa Conte reported Q1 2026 net revenue +816% YoY and +527% QoQ, driven by out-license with Future Pak.
Company targets NDA for crofelemer formulation in mid-2027 and seeks development/commercialization partner.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-240645
form_type: 8-K
ticker: JAGX
cik: 0001585608
company_name: Jaguar Health, Inc.
filed_at: 2026-05-27T13:10:06+00:00
discovered_at: 2026-05-27T13:11:00.391862+00:00
generated_at: 2026-05-27T13:14:00.035938+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-240645
json_url: https://secwatch.observer/filing/0001193125-26-240645.json
markdown_url: https://secwatch.observer/filing/0001193125-26-240645.md
text_url: https://secwatch.observer/filing/0001193125-26-240645.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/0001193125-26-240645-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/d129501d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

MBOT

Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.

Microbot Medical Inc. May 26, 2026, 8:30 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

RGTI

Rigetti signs LOI for up to $100M CHIPS Act award for quantum R&D; government to receive equity

Rigetti Computing, Inc. May 21, 2026, 7:30 AM ET regulatory Items 3.02, 8.01, 7.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ELTP

Elite Pharmaceuticals files ANDA for generic anticoagulant; $26B brand market, no generic available

ELITE PHARMACEUTICALS INC /NV/ June 1, 2026, 7:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

REPL

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc. May 29, 2026, 9:56 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BDX

BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable

BECTON DICKINSON & CO May 29, 2026, 8:39 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-26-240645

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.